hepatitis
-
China’s hepatitis B virus market will grow to nearly $900 million in 2015
Decision Resources forecasts that the hepatitis B virus (HBV) market in China will grow from $601 million in 2010 to nearly $900 million in 2015. According to the Emerging Markets report, Hepatitis B Virus in China, despite an increase in the drug-tr…
hepatitis | 14 June 2011
-
Roche, Merck establish strategic agreements in hepatitis C fight
Non-exclusive agreements focused on improving treatment, diagnosis and awareness of chronic hepatitis C for patients.
hepatitis | 17 May 2011
-
Boehringer Ingelheim’s lead hepatitis C compound moves into phase 3
Boehringer Ingelheim announced the study outline for the pivotal phase 3 clinical trials designed to evaluate BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naive and experienced patients with chronic genotype-1 …
hepatitis | 04 April 2011
-
Bristol-Myers Squibb announces results of phase 2 dose-ranging study of hepatitis C patients
Bristol-Myers Squibb announced results from a phase 2 clinical trial which achieved sustained virologic response 12 weeks post-treatment in up to 92 percent of treatment-naive patients chronically infected with hepatitis C genotype 1. The treatment i…
hepatitis | 31 March 2011
-
Hepatitis C in Singapore
Prevalence and incidence of Hepatitis C in Singapore will remain stable because of widespread awareness.
hepatitis | 01 March 2011
-
US FDA approves first automated molecular test for assessing hepatitis B treatment
Abbott receives approval from US FDA to market the RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sa…
hepatitis | 23 September 2010
-
Rapid blood test for hepatitis C virus approved
FDA approved the first rapid blood test in the US for antibodies to the hepatitis C virus (HCV) in whole blood specimens (from venipuncture), for individuals 15 years and older. The OraQuick HCV Rapid Antibody Test, a test strip for the detection of …
hepatitis | 02 July 2010
-
High Hepatitis B & C Prevalence in Asia
According to Datamonitor , China, Taiwan and South Korea represent highly endemic areas for viral hepatitis, with prevalence rates ranging from 4-13% for Hepatitis B (HBV) and from 1-4% for Hepatitis C (HCV). While there are several therapeutic o…
hepatitis | 10 June 2010
-
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData has released a report entitled, “Hepatitis C – Drug Pipeline Analysis and Market Forecasts to 2016â€. It contains key trends shaping and driving the global Hepatitis C market, insights into the prevalent competitive landscape, emergi…
hepatitis | 03 June 2010
-
Nonalcoholic Steatohepatitis
In a report published by GlobalData, it is estimated that the Nonalcoholic Steatohepatitis (NASH) market was worth US$1.8 billion in 2009. The major reason for the limited market revenues is that there is no approved drug for the treatment of NASH. …
hepatitis | 01 June 2010
